 Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a specialty pharmaceutical company, today announced the results of a Level 1 Trauma Center study recently published in the Journal of Orthopedic Trauma. Results demonstrate Caldolor ibuprofen Injection significantly reduces the quantity of opioids required to manage pain after a traumatic injury with fracture. In addition, the time to first narcotic medication was longer in the Caldolor group than with hospital standard of care. Further, pain was managed better in the Caldolor group compared to standard of care narcotics1. 